Use of adenovirus type-5 vectored vaccines: a cautionary tale
| dc.creator | Buchbinder, Susan P. | |
| dc.creator | McElrath, M. Juliana | |
| dc.creator | Dieffenbach, Carl | |
| dc.creator | Corey, Lawrence | |
| dc.date.accessioned | 2020-10-21T21:06:44Z | |
| dc.date.available | 2020-10-21T21:06:44Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Indisponível. | pt_BR |
| dc.identifier.citation | BUCHBINDER, S. P. et al. Use of adenovirus type-5 vectored vaccines: a cautionary tale. The Lancet, [S.l.], 2020. | pt_BR |
| dc.identifier.uri | https://repositorio.ufla.br/handle/1/43533 | |
| dc.identifier.uri | https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32156-5/fulltext | pt_BR |
| dc.language | en_US | pt_BR |
| dc.rights | openAccess | pt_BR |
| dc.source | The Lancet | pt_BR |
| dc.subject | COVID-19 - Vaccine | pt_BR |
| dc.subject | Recombinant adenovirus type-5 (Ad5) | pt_BR |
| dc.title | Use of adenovirus type-5 vectored vaccines: a cautionary tale | pt_BR |
| dc.type | Artigo | pt_BR |
Arquivos
Licença do pacote
1 - 1 de 1
Carregando...
- Nome:
- license.txt
- Tamanho:
- 953 B
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
